Garry P. Duffy

773 citations
32 papers · 488 indexed · h-index 13

Garry P. Duffy

29 papers receiving 485 citations

Peers

Garry P. Duffy
Comparison fields: 5 of 86
  • Biomaterials 160
  • Molecular Medicine 26
  • Biomedical Engineering 198
  • Surgery 186
  • Pharmaceutical Science 22
Replace Xuehui Chu with:
Xuehui Chu China
Zhi Zheng China
Amanda N. Steele United States
Idoia Gallego Spain
Yasumoto Matsumura Japan
Liyin Shen China
Morteza Heidarzadeh Iran
Sung Mook Lim South Korea
Justin Morrissette‐McAlmon United States
Guoqing Li China
Garry P. Duffy relative to Xuehui Chu China Xuehui Chu's profile →
Citations per field
00.5×1.5×1.9×
Xuehui Chu · 1×
Citations per year

Countries citing papers authored by Garry P. Duffy

Since Specialization
Citations

This map shows the geographic impact of Garry P. Duffy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garry P. Duffy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garry P. Duffy more than expected).

Fields of papers citing papers by Garry P. Duffy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garry P. Duffy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garry P. Duffy. The network helps show where Garry P. Duffy may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Garry P. Duffy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Garry P. Duffy Line = papers co-authored together Garry P. Duffy links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20242
3 20235
4 20239
5 202254
6 202110
7 202137
8 202113
9 202135
10 20203
11 202037
12 201928
13 201924
14 20191
15 201910
16 201878
17 201825
18 201833
19
Diabetes knowledge deficits in adolescents and young adults with type 1 diabetes mellitus
20041
20 19670

About Garry P. Duffy

Garry P. Duffy is a scholar working on Biomaterials, Surgery and Transplantation, having authored 32 papers that have together received 488 indexed citations. Recurring topics across this work include Electrospun Nanofibers in Biomedical Applications (14 papers), Tissue Engineering and Regenerative Medicine (13 papers), 3D Printing in Biomedical Research (7 papers), Pancreatic function and diabetes (5 papers), Mesenchymal stem cell research (3 papers), Polymer Nanocomposite Synthesis and Irradiation (2 papers), CAR-T cell therapy research (2 papers) and Diabetes Management and Research (2 papers). The work is most often cited by research in Biomaterials (160 citations), Molecular Medicine (26 citations) and Biomedical Engineering (198 citations). Garry P. Duffy has collaborated with scholars based in Ireland, United States and Netherlands. Frequent co-authors include Eimear B. Dolan, Aamir Hameed, Ellen T. Roche, Janice O’Sullivan, Robert Wylie, Vladimı́r Velebný, Martin Pravda, William Whyte, Michael J. Kerin and Nikolay V. Vasilyev. Their work appears in journals such as SHILAP Revista de lepidopterología, Advanced Drug Delivery Reviews and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026